Showing 1 - 10 of 10
AbstractIn this paper we compare different approaches and show the need for systematic requirementsengineering for hybrid products beyond disciplinary boundaries. Hybrid products consist ofcombinations of hardware, software and service elements. The purpose of this paper is to report ona...
Persistent link: https://www.econbiz.de/10005871027
More and more companies realign their competencies to offer integrated bundlesof products and services with the goal to solve customer problems (Leimeister etal. 2009). The customers are not interested in products or services per se, but theywant their problems to be solved (Böhmann und Krcmar...
Persistent link: https://www.econbiz.de/10009022179
Eine möglichst vollständige Erfüllung von Kundenanforderungen und eine Differenzierungvon Wettbewerbern sind zwei Faktoren, die produzierende oder dienstleistungsanbietendeUnternehmen beeinflussen (Böhmann und Krcmar 2007,Leimeister und Glauner 2008). Deswegen ändern viele Unternehmen ihre...
Persistent link: https://www.econbiz.de/10009022180
Persistent link: https://www.econbiz.de/10001799719
We analyze the frequency and nature by which new firms are acquired by established businesses. Acquisitions are often considered to reflect a technology transfer process and to also constitute one way in which a “symbiosis” between new technology-based firms (NTBFs) and established...
Persistent link: https://www.econbiz.de/10010945043
This study investigates the determinants of R&D expenditures in the Swedish pharmaceutical industry from the 1960s to the mid 1990s. Various proxies for the rate of return of R&D (e.g. expected profit, sales and R&D productivity) as well as the availability of internal funding (proxied by past...
Persistent link: https://www.econbiz.de/10005077278
, focusing on the relation between institutions and innovation practices and taking into account the diversity of actors …
Persistent link: https://www.econbiz.de/10010818687
This study investigates the determinants of R&D expenditures in the Swedish pharmaceutical industry from the 1960s to the mid 1990s. Various proxies for the rate of return of R&D (e.g. expected profit, sales and R&D productivity) as well as the availability of internal funding (proxied by past...
Persistent link: https://www.econbiz.de/10008764489
It is widely accepted that firms in peripheral regions benefit to a lesser extent from local knowledge spillovers than firms located in agglomerations or industrial clusters. This paper investigates the extent to which innovative firms in peripheral regions compensate for the lack of access to...
Persistent link: https://www.econbiz.de/10011105519
We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …
Persistent link: https://www.econbiz.de/10010569681